Roivant Sciences News

Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Teladoc (TDOC) and Gilead Sciences (GILD)

TipRanksApr 26 07:50 ET

Critical Insights From Roivant Sciences Analyst Ratings: What You Need To Know

BenzingaApr 22 11:01 ET

Roivant Sciences Analyst Ratings

BenzingaApr 22 06:32 ET

Analysts Are Bullish on Top Healthcare Stocks: Reviva Pharmaceuticals Holdings (RVPH), Roivant Sciences (ROIV)

TipRanksApr 22 06:20 ET

Roivant Sciences Analyst Ratings

BenzingaApr 3 11:16 ET

Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Terns Pharmaceuticals (TERN) and Altimmune (ALT)

TipRanksApr 3 08:11 ET

HC Wainwright Raises Roivant Sciences Price Target to $18 From $17, Maintains Buy Rating

MT NewswiresApr 3 07:11 ET

Buy Rating Affirmed for Roivant Sciences Amid Brepocitinib Success and Strategic Share Repurchase Program

TipRanksApr 3 06:26 ET

Roivant Sciences Analyst Ratings

BenzingaApr 3 05:14 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Inari Medical (NARI) and Roivant Sciences (ROIV)

TipRanksApr 3 05:03 ET

Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV) and Inmune Bio (INMB)

TipRanksApr 2 16:10 ET

Roivant Sciences Analyst Ratings

BenzingaMar 25 12:13 ET

TD Cowen Keeps Their Buy Rating on Roivant Sciences (ROIV)

TipRanksMar 13 07:15 ET

TD Cowen Sticks to Their Buy Rating for Roivant Sciences (ROIV)

TipRanksMar 6 07:37 ET

Buy Rating Affirmed for Roivant Sciences: Undervaluation and Promising Pipeline Drive Positive Outlook

TipRanksFeb 15 01:17 ET

Roivant Sciences Analyst Ratings

BenzingaFeb 14 11:45 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE) and Roivant Sciences (ROIV)

TipRanksFeb 14 08:00 ET

Hold Rating on Roivant Sciences Amidst Mixed Performance and Strategic Focus

TipRanksFeb 14 05:25 ET

Goldman Sachs Keeps Their Buy Rating on Roivant Sciences (ROIV)

TipRanksFeb 13 08:16 ET

Roivant Sciences Analyst Ratings

BenzingaJan 5 10:06 ET